Results 231 to 240 of about 279,339 (314)

ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD‐Mediated EMT Signaling Pathway

open access: yesAdvanced Science, EarlyView.
This study identifies STAU2 as an oncogenic RNA‐binding protein (RBP) with elevated expression in pancreatic ductal adenocarcinoma (PDAC), where its high levels are significantly correlated with metastatic progression. It elucidates that STAU2 directly binds and regulates PALLD, while mediating the functional role of IQGAP1, thereby driving metastasis ...
Jiayu Ding   +16 more
wiley   +1 more source

Investigation of sphingolipid-related genes in lung adenocarcinoma. [PDF]

open access: yesFront Mol Biosci
Mao J   +6 more
europepmc   +1 more source

Adenocarcinoma lung in a painter

open access: yesJournal of Cancer Research and Therapeutics, 2011
Kumar, Arinaganhalli Subbanna. Praveen   +3 more
openaire   +2 more sources

EGFR‐TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer

open access: yesAdvanced Science, EarlyView.
Drug‐tolerant persister (DTP) cells emerge early during EGFR‐TKI treatment, preceding the development of acquired resistance. Elevated DPP4 in DTP cells drives metabolic reprogramming and antioxidant adaptation, promoting cell survival under drug pressure.
Yuanzhou Zhang   +7 more
wiley   +1 more source

Immune infiltration and drug treatment response of angiogenesis-related LncRNA in lung adenocarcinoma. [PDF]

open access: yesMedicine (Baltimore)
Lei Q   +7 more
europepmc   +1 more source

Evaluation of Biological Malignancy of Primary Lung Adenocarcinoma Using Two-Dimensional Polyacrylalnide Gel Electrophoresis.

open access: bronze, 2000
Takashi Hirano   +9 more
openalex   +2 more sources

Cascade‐Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatment Resistance in Pancreatic Cancer

open access: yesAdvanced Science, EarlyView.
The aberrant adenosine metabolism leads to chemoresistance and immunosuppressive microenvironment. A versatile albumin‐polyplexes conjugated nanoparticle B‐PDEA@CPA is prepare for the codelivery of gemcitabine and siCD39. The nanoparticle releases gemcitabine‐loaded albumin upon microenvironment to achieve promoted penetration and cellular uptake ...
Hongrui Fan   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy